99
Participants
Start Date
May 10, 2018
Primary Completion Date
September 30, 2022
Study Completion Date
March 28, 2023
Hyperbaric Oxygen Therapy
The intervention consists of exposure to hyperbaric oxygen at 2.5 atmospheres absolute (ATA) for a total of 2 hours, in a single see-through hyperbaric chamber, breathing 100% oxygen for 90 minutes while subjects are resting in supine position. During the 2 hours, there will be compression and decompression phases for 15 minutes each in which subjects will be breathing compressed environmental air (21% oxygen).
No Hyperbaric Oxygen Therapy
The reference arm will not receive hyperbaric oxygen therapy prior to hematopoietic stem cell transplant.
Wilmot Cancer Institute, University of Rochester Medical Center, Rochester
University of Kentucky Markey Cancer Center, Lexington
The University of Kansas Cancer Center, Fairway
Omar Aljitawi
OTHER